Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about MRK

Recent news which mentions MRK

...

8 9 10 11 12 13 14 15 16

...

Merck's Mumps Vaccine Controversy: Class-Action Lawsuit Alleges Anticompetitive Behavior, Court Shields From Liability

October 08, 2024

Merck Touts Phase 3 Success For $20B Cancer Drug Keytruda In Untreated Head And Neck Cancer Patients

October 08, 2024

10 Health Care Stocks Whale Activity In Today's Session

October 07, 2024

2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts

October 07, 2024

Is It Time to Buy September's Worst-Performing Dow Jones Stocks?

October 05, 2024

Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses

October 04, 2024

Could Summit Therapeutics Become the Next Merck?

October 04, 2024

Demystifying Merck & Co: Insights From 8 Analyst Reviews

October 03, 2024

Exploring The Competitive Space: Merck & Co Versus Industry Peers In Pharmaceuticals

October 03, 2024

The Covid Era Tech Promises To Reinvent Cancer Treatment

October 01, 2024

2 High-Potential Growth Stocks You Shouldn't Overlook

September 29, 2024

Is Merck Stock a Buy?

September 29, 2024

Evaxion Biotech Partners With Merck To Expand Vaccine Development

September 26, 2024

This Is What Whales Are Betting On Merck & Co

September 25, 2024

FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients

September 25, 2024

Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years

September 25, 2024

Merck's Experimental Favezelimab/Keytruda Combo Fails In Late-Stage Colorectal Cancer Study

September 25, 2024

Merck & Co Unusual Options Activity For September 23

September 23, 2024

Pfizer Advances On Its Cancer Journey

September 20, 2024

Is It Too Late to Buy ServiceNow Stock?

September 20, 2024

Merck's Keytruda Secures First FDA-Approval For Rare Form Aggressive Cancer

September 18, 2024

Behind the Scenes of Merck & Co's Latest Options Trends

September 18, 2024

This Company Generates No Revenue and Its Market Cap Is Over $20 Billion. Here's Why That Valuation May Not Be All That Ridiculous.

September 18, 2024

Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030

September 18, 2024

Competitor Analysis: Evaluating Merck & Co And Competitors In Pharmaceuticals Industry

September 17, 2024

Merck/Daiichi Sankyo Partnered Lung Cancer Candidate Meets Primary Goal In Late-Stage Study

September 17, 2024

A Closer Look at 8 Analyst Recommendations For Merck & Co

September 16, 2024

NuCana Resistant Melanoma Treatment Data Shows Providing Some Relief After Disappointing Colorectal Cancer Data, Stock Surges

September 16, 2024

Where Will Merck Stock Be in 5 Years?

September 14, 2024

Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target

September 13, 2024

...

8 9 10 11 12 13 14 15 16

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.